<p>Senior Principal Scientific Advisor Stan Spence joins me to discuss off-target liability: what happens when a drug misses its target? What are the risks to the patient if the off-target effects aren't caught early? Has there ever been an example of an off-target effect being beneficial to the patient? Find out here!</p>

Senior Principal Scientific Advisor Stan Spence joins me to discuss off-target liability: what happens when a drug misses its target? What are the risks to the patient if the off-target effects aren't caught early? Has there ever been an example of an off-target effect being beneficial to the patient? Find out here!

Ep. 66: When Drug Candidates Miss the Mark: Off-Target Liability

Sounds of Science is a monthly podcast about beginnings: how a molecule becomes a drug, how a rodent elucidates a disease pathway, how a horseshoe crab morphs into an infection fighter. The podcast is produced by Eureka,  the scientific blog of Charles River, a contract research organization for drug discovery and development. Tune in and begin the journey.

Science

Technology

Sounds of Science is a monthly podcast about beginnings: how a molecule becomes a drug, how a rodent elucidates a disease pathway, how a horseshoe crab morphs into an infection fighter. The podcast is produced by Eureka, the scientific blog of Charles River, a contract research organization for drug discovery and development. Tune in and begin the journey.

Share Ep. 66: When Drug Candidates Miss the Mark: Off-Target Liability

Sign up to save your podcasts

Ep. 66: When Drug Candidates Miss the Mark: Off-Target Liability

Ep. 66: When Drug Candidates Miss the Mark: Off-Target Liability